[1]王国玲,张博刚,郭 娟,等.脑梗死患者血清miR-181d和miR-210水平表达与颈动脉狭窄程度及预后的相关性研究[J].现代检验医学杂志,2021,36(06):64-69.[doi:10.3969/j.issn.1671-7414.2021.06.013]
　WANG Guo-ling,ZHANG Bo-gang,GUO Juan,et al.Correlation between Serum miR-181d and miR-210 Levels in Patients with Cerebral Infarction and the Degree of Carotid Artery Stenosis and Prognosis[J].Journal of Modern Laboratory Medicine,2021,36(06):64-69.[doi:10.3969/j.issn.1671-7414.2021.06.013]
点击复制

脑梗死患者血清miR-181d和miR-210水平表达与颈动脉狭窄程度及预后的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第36卷
期数:
2021年06期
页码:
64-69
栏目:
论　著
出版日期:
2021-12-15

文章信息/Info

Title:
Correlation between Serum miR-181d and miR-210 Levels in Patients with Cerebral Infarction and the Degree of Carotid Artery Stenosis and Prognosis
文章编号:
1671-7414（2021）06-064-06
作者:
王国玲; 张博刚; 郭 娟; 马 萌; 王荣辉; 闫喜格
（邢台市第三医院神经内科五病区,河北邢台 054000）
Author(s):
WANG Guo-ling;  ZHANG Bo-gang;  GUO Juan;  et al
（No.5 Department of Neurology, the Third Hospital of Xingtai City,Hebei Xingtai 054000,China）
关键词:
脑梗死; 血清微小RNA-181d; 血清微小RNA-210; 颈动脉狭窄
分类号:
R743.33；R392.11
DOI:
10.3969/j.issn.1671-7414.2021.06.013
文献标志码:
A
摘要:
目的　探讨分析脑梗死（cerebral infarction）患者血清microRNA-181d（miR-181d），microRNA-210（miR-210）水平表达与颈动脉狭窄程度及预后的相关性。方法　选取2017年10月～2019年10月邢台市第三医院收治的480例脑梗死患者，根据颈部超声结果将其分为颈动脉狭窄组278例和无颈动脉狭窄组202例。检测两组患者血清miR-181d和miR-210水平，分析其水平变化与颈动脉狭窄的关系。然后随访其半年内预后情况，根据预后情况将患者分为预后良好组192例和预后不良组288例，并对影响预后不良因素进行分析比较。对影响预后不良的相关高危因素进行单因素χ2检验，并筛选出可能影响的单因素，再进行多因素Logistic回归分析，根据以上因素绘制ROC曲线，评估其对预测预后不良的价值。结果　颈动脉狭窄组患者血清miR-181d表达量水平显著高于无颈动脉狭窄组，而miR-210表达量水平均显著低于无颈动脉狭窄组，差异均有统计学意义（t=17.513，10.888，均P＜0.05）。而颈动脉轻度狭窄患者血清miR-181d表达量显著低于中度狭窄、重度狭窄患者，而颈动脉轻度狭窄患者血清miR-210表达量显著高于中度狭窄和重度狭窄患者，差异均有统计学意义（t=5.874，6.246，2.172和5.427，均P＜0.05）。随访半年内预后情况，预后良好192例，占40.00%；预后不良288例，占60.00%。两组各危险因素比较，性别、年龄、并发高血脂、并发冠心病、吸烟史、饮酒史等资料较为接近，差异无统计学意义（χ2=0.237~2.475，均P＞0.05）。而两组高血压、糖尿病、心房颤动、血清miR-181d和血清miR-210差异有统计学意义（χ2=8.539~21.713，均P＜0.05）。将有统计学意义的危险单因素纳入多因素回归分析，采用Logistic回归方程进行分析，结果显示，血清miR-181d表达量升高（OR=1.164，95%CI：1.137~1.192），血清miR-210表达量降低（OR=10.196，95%CI：6.677～15.570）是脑梗死患者预后不良的独立危险因素（OR＞1，P＜0.05）。并且血清miR-181d预测脑梗死患者预后不良的ROC曲线下面积为0.76（95% CI：1.013~1.124），敏感度和特异度分别为71.23%和73.45%，而血清miR-210预测脑梗死患者预后不良的ROC曲线下面积为0.79（95% CI：1.125~1.206），敏感度和特异度分别为73.42%和75.36%，联合检测的ROC曲线为0.83（95% CI：1.147~1.235），敏感度和特异度分别为79.33%和82.41%。结论　血清miR-181d水平与预后不良呈正相关关系，而血清miR-210水平与预后不良呈负相关关系，血清miR-181d和miR-210是脑梗死患者预后不良的独立影响因素，检测其水平表达对于预测脑梗死患者不良事件发生具有较高价值，值得临床推广。
Abstract:
Objective　To explore and analyze the correlation between serum miR-181d and miR-210 levels in patients with cerebral infarction and the degree of carotid artery stenosis and prognosis. Methods　480 patients with cerebral infarction admitted to the Third Hospital of Xingtai City from October 2017 to October 2019 were selected and divided into carotid artery stenosis group 278 cases and carotid artery stenosis group 202 cases based on the results of cervical ultrasound. The serum levels of miR-181d and miR-210 were detected in the two groups of patients, and the relationship between their changes and carotid artery stenosis was analyzed. Then the prognosis was followed up for half a year. According to the prognosis, the patients were divided into a good prognosis group of 192 cases and a poor prognosis group of 288 cases, and then the adverse factors affecting the prognosis were analyzed and compared. The single factor χ2 test analysis was performed on the related high-risk factors affecting the poor prognosis, and the single factors that may affect the prognosis were screened out, and then the multi-factor Logistic regression analysis was performed, and then the ROC curve was drawn based on the above factors to evaluate its value in predicting the poor prognosis. Results　 The serum levels of miR-181d and miR-210 in the carotid artery stenosis group were significantly lower than those in the carotid artery stenosis group (t=17.513, 10.888, all P<0.05). The serum levels of miR-181d and miR-210 in patients with mild carotid artery stenosis were significantly higher than those in patients with moderate or severe carotid stenosis, and the difference reached statistical significance (t=5.874, 6.246, 2.172 and 5.427, all P<0.05). The prognosis was followed up within half a year, 192 cases had a good prognosis, accounting for 40.00%, the prognosis was poor 288 cases, accounting for 60.00%. Comparing the risk factors of the two groups, the data of gender, age, combined hyperlipidemia, combined coronary heart disease, smoking history, and drinking history were relatively similar, and the difference was not statistically significant( χ2=0.237~0.275, all P>0.05). There were significant differences in hypertension, diabetes, atrial fibrillation, serum miR-181d, and serum miR-210 between the two groups (χ2=8.539~21.713, all P<0.05). The statistically significant single risk factors were included in the multivariate regression analysis, and the logistic regression equation was used for analysis. The results showed that serum miR-181d expression increased (OR=1.164, 95% CI: 1.137~71.192), serum miR- Decreased expression of 210 (OR=10.196, 95% CI: 6.677~5.570) was an independent risk factor for poor prognosis in patients with cerebral infarction (OR＞1, P＜0.05). The area under the ROC curve of serum miR-181d predicting poor prognosis of cerebral infarction was 0.76 (95% CI: 1.013~1.124), and the sensitivity and specificity at this time were 71.23% and 73.45%, respectively. The area under the ROC curve of serum miR-210 predicting poor prognosis of cerebral infarction was 0.79 (95% CI: 1.125~1.206), the sensitivity and specificity at this time were 73.42% and 75.36%, respectively, and the ROC curve of the combined detection was 0.83 (95% CI: 1.147~1.235), the sensitivity and specificity were 79.33% and 82.41%, respectively.Conclusion　 The serum miR-181d level was positively correlated with the poor prognosis, while the serum miR-210 level was negatively correlated with the poor prognosis. Serum miR-181d and miR-210 are independent factors influencing the poor prognosis of patients with cerebral infarction. Predicting the occurrence of adverse events in patients with cerebral infarction has good value and is worthy of clinical promotion.

参考文献/References:

[1] 刘燕，赵青，何琤画，等．MRI 与颈动脉SMI 诊断脑梗死患者颈动脉狭窄的效能比较[J]. 西南国防医药,2019,29(3):382-384.LIU Yan, ZHAO Qing, HE Chenghua, et al. Comparisonof MRI and carotid artery SMI in the diagnosisof carotid artery stenosis in patients with cerebralinfarction[J]. Medical Journal of National DefendingForces in Southwest China, 2019, 29(3): 382-384.
[2] 何强华, 汪毅宏, 刘强, 等. 老年脑梗死患者miR-145 IGF1R 水平与颈动脉狭窄的相关性[J]. 河北医学, 2019, 25 (1):131-135.HE Qianghua, WANG Yihong, LIU Qiang, et al. Thecorrelation between the levels of miR-145 and IGF1Rand carotid artery stenosis in elderly patients withcerebral infarction [J]. Hebei Medicine, 2019, 25(1):131-135.
[3] 耿彪，宋婷阁，张鹏举，等．血清炎症因子与老年急性脑梗死颈动脉粥样硬化及预后的关系[J]. 现代检验医学杂志,2019,34(4):120-123, 127.GENG Biao, SONG Tingge, ZHANG Pengju, et al.Relationship between flammatory factors in serum andcarotid atherosclerosis and prognosis in elderly patientswith acute cerebral infarction [J]. Journal of ModernLaboratory Medicine, 2019,34(4): 120-123,127.
[4] SUN Wei, LI Guangsheng, ZENG Xiangjun, et al.Clinical and imaging characteristics of cerebralinfarction in patients with nonvalvular atrial fibrillationcombined with cerebral artery stenosis[J]. Journal ofAtherosclerosis and Thrombosis, 2018, 25(8): 720-732.
[5] 李芳，潘发光，刘芳．脑梗死患者血清Vaspin，Apelin，Chemerin 与颈动脉斑块性质及预后的关系[J]. 热带医学杂志, 2019, 19(3):346-349,368.LI Fang, PAN Faguang, LIU Fang. The relationshipsbetween serum Vaspin, Apelin, Chemerin with carotidplaque characteristics and prognosis of patients withcerebral infarction [J]. Journal of Tropical Medicine,2019, 19(3):346-349,368.
[6] YUAN Tao, REN Guoli, HU Xianing, et al. Addedassessment of middle cerebral artery and atrialfibrillation to FLAIR vascular hyperintensity-DWImismatch would improve the outcome prediction ofacute infarction in patients with acute internal carotidartery occlusion[J]. Neurological Sciences, 2019,40(12): 2617-2624.
[7] BADACZ R, PRZEWLOCKI T, GACON J, et al.Circulating miRNA levels differ with respect to carotidplaque characteristics and symptom occurrence inpatients with carotid artery stenosis and provideinformation on future cardiovascular events[J]. PostepyKardiologii Interwencyjnej, 2018, 14(1): 75-84.
[8] 任厚伟，顾彬，郭婷，等．急性脑梗死患者并发脑卒中相关性肺炎外周血T 淋巴细胞亚群与炎症因子的临床分析[J]. 中华临床感染病杂志, 2020,13(6):406-411.REN Houwei, GU Bin, GUO Ting, et al. Predictivevalue of T lymphocyte subsets and inflammatoryfactors for occurrence and severity of stroke associatedpneumonia in patients with acute cerebral infarction [J].Chinese Journal of Clinical Infectious Diseases, 2020,13(6):406-411.
[9] 雷琦, 朱婷鸽, 刘蕊. 急性脑梗死患者外周血T 细胞变化与神经损害、炎症及应激反应的相关性[J]. 海南医学院学报, 2019, 25(9): 654-657.LEI Qi, ZHU Tingge, LIU Rui. The correlation ofperipheral blood T cell changes with nerve damage,inflammatory response and stress response in patientswith acute cerebral infarction [J]. Journal of HainanMedical University, 2019, 25(9): 654-657.
[10] PARK S E, CHOI D S, BAEK H J, et al. Endovasculartherapy of acute ischemic stroke related to tandemocclusion: comparison of occlusion and severe stenosisof the proximal cervical internal carotid artery[J]. TheBritish Journal of Radiology, 2019, 92(193): 20180051.
[11] 陈南耀，余丹．联合检测血清miR-124 与miR-182的表达水平对急性脑梗死诊断与预后评估的价值[J]. 中国动脉硬化杂志, 2019, 27(6): 502-506.CHEN Nanyao, YU Dan. The value of combineddetection of the expression levels of serummicroRNA-124 and microRNA-182 in diagnosis andprognosis of acute cerebral infarction [J]. ChineseJournal of Arteriosclerosis, 2019, 27(6): 502-506.
[12] 刘小江，李军，管义祥．抑制microRNA-27b 调控Nrf2/ARE 信号通路对高血压性脑出血大鼠模型脑损伤的机制研究[J]. 河北医学, 2020,26 (1): 76-80.LIU Xiaojiang, LI Jun, GUAN Yixiang. InhibitingmicroRNA-27b regulation of Nrf2/ARE signaling pathwayon brain injury in rat model of hypertensive cerebralhemorrhage [J]. Hebei Medicine, 2020,26 (1): 76-80.
[13] GACO? J, BADACZ R, ST?PIE? E, et al. Diagnosticand prognostic micro-RNAs in ischaemic stroke due tocarotid artery stenosis and in acute coronary syndrome:a four-year prospective study[J]. Kardiologia Polska,2018, 76(2): 362-369.
[14] 詹婧婧, 刘泉, 李铮, 等. 创伤性脑损伤相关microRNA 的研究进展[J]. 中国法医学杂志,2020,35(6):651-654,659.ZHAN Jingjing, LIU Quan, LI Zhen, et al. Researchprogress of microRNA related to traumatic brain injury[J]. Chinese Journal of Forensic Medicine, 2020, 35(6):651-654,659.
[15] ALSERR A H, ELWAN H, ANTONOPOULOS C N,et al. Using serum s100-β protein as a biomarker forcomparing silent brain injury in carotid endarterectomyand carotid artery stenting[J]. International Angiology:2019, 38(2): 136-142.
[16] LACKEY A R, ERBEN Y, FRANCO J, et al.Transcarotid artery revascularization results in lowrates of periprocedural neurologic events, myocardialinfarction, and death[J]. Current Cardiology Reports,2020, 22(1): 3.
[17] 杨娑娑， 王金． 轻度创伤性脑损伤患者血清microRNA-210 与血小板水平及与认知功能的关系[J]. 血栓与止血学, 2020, 26(3): 434-435,438.YANG Suosuo, WANG Jin. The relationship betweenserum microRNA-210 , platelet level and cognitivefunction in patients with mild traumatic brain injury [J].Chinese Journal of Thrombosis and Hemostasis, 2020,26(3): 434-435,438.
[18] 程永红，肖小平．中重度颅脑损伤并发脑梗死患者血清miRNA-124 与miRNA-210 表达的临床意义[J].现代检验医学杂志,2018,33(3):83-87.CHENG Yonghong, XIAO Xiaoping. Clinicalapplication in detecting serum microRNA-124 andmicroRNA-210 in the moderately severe craniocerebralinjury complicated with the traumatic cerebralinfarction [J]. Journal of Modern Laboratory Medicine,2018,33(3): 83-87.
[19] KASHYAP V S, SCHNEIDER P A, FOTEH M, etal. Early outcomes in the ROADSTER 2 study oftranscarotid artery revascularization in patients withsignificant carotid artery disease[J]. Stroke, 2020,51(9): 2620-2629.
[20] 郭春宣，钟纯正，李琦，等. 老年急性缺血性脑卒中患者血清微小RNA-24 和微小RNA-29b 表达及神经功能预后评估价值[J]. 中华危重病急救医学,2020,32(1):78-82.GUO Chunxuan, ZHONG Chunzheng, LI Qi, et al.Expressions and neural function prognostic evaluationof serum microRNA-24 and microRNA-29b in elderlypatients with acute ischemic stroke [J]. Chinese CriticalCare Medicine, 2020, 32(1):78-82.
[21] 单海雷, 焦光美, 窦志杰, 等. 脑梗死过程中微RNA-181d 和肿瘤坏死因子α 的表达及机制研究[J].重庆医学, 2019, 48(7) 1094-1098.SHAN Hailei, JIAO Guangmei, DOU Zhijie, et al.The expression of microRNA-181d and tumor necrosisfactor-α in cerebral infarction and its mechanism [J].Chongqing Medicine, 2019, 48(7) 1094-1098.
[22] FRAZIER S, MCBRIDE M W, MULVANA H, et al.From animal models to patients: the role of placentalmicroRNAs, miR-210, miR-126, and miR-148a/152 inpreeclampsia[J]. Clinical Science (London, England :1979), 2020, 134(8): 1001-1025.
[23] 张玉坤，赵阳，金蔚涛，等．颈动脉重度狭窄合并冠状动脉病变的联合手术[J]. 中华医学杂志, 2019,99(39):3077-3080.ZHANG Yukun, ZHAO Yang, JIN Weitao, et al.Simultaneous treatments in patients with severe carotidartery stenosis and coronary artery disease [J]. NationalMedical Journal of China, 2019, 99(39):3077-3080.
[24] ?ZYAL?IN S, DIKEN A, YAL?INKAYA A, et al.Carotid artery stenosis in asymptomatic patientsundergoing coronary artery bypass grafting: who andwhen should be screened[J]. Kardiologia Polska, 2021,79(1): 25-30.
[25] L? Weibo, ZHANG Tao, ZHAO Hongwei, et al.Diagnostic value of miR-186-5p for carotid arterystenosis and its predictive significance for futurecerebral ischemic event[J]. Diagnostic Pathology, 2020,15(1): 585-590.

相似文献/References:

[1]王兴宁,李 慧,米思蓉,等.脑梗死患者血清同型半胱氨酸水平与颈动脉粥样硬化的相关性研究[J].现代检验医学杂志,2015,30(03):46.[doi:10.3969/j.issn.1671-7414.2015.03.013]
　WANG Xing-ning,LI Hui,MI Si-rong,et al.Analysis of Relationship between Homocysteine and Carotid Atherosclerosis in Patients with Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2015,30(06):46.[doi:10.3969/j.issn.1671-7414.2015.03.013]
[2]张瑞.脑梗死患者血清同型半胱氨酸、血浆叶酸和维生素B12水平的相关性研究[J].现代检验医学杂志,2015,30(05):118.[doi:10.3969/j.issn.1671-7414.2015.05.036]
　ZHANG Rui.Correlation Study on Homocysteine，Plasma Folate and Vitamin B12 Levels in Serum of Cerebral Infarction Patients[J].Journal of Modern Laboratory Medicine,2015,30(06):118.[doi:10.3969/j.issn.1671-7414.2015.05.036]
[3]文关良,剌 梅.脂蛋白相关磷脂酶A2在颈动脉斑块性脑梗死中的临床意义[J].现代检验医学杂志,2017,32(02):117.[doi:10.3969/j.issn.1671-7414.2017.02.032]
　WEN Guan-liang,LA Mei.Clinical Study of LP-PLA2 in Carotid Plaques Cerebral Infarction Patients[J].Journal of Modern Laboratory Medicine,2017,32(06):117.[doi:10.3969/j.issn.1671-7414.2017.02.032]
[4]程俊杰,李 静,梁西强,等.高血压并发脑梗死患者不同血脂分层下病死率的分析研究[J].现代检验医学杂志,2017,32(03):97.[doi:10.3969/j.issn.1671-7414.2017.03.026]
　CHENG Jun-jie,LI Jing,LIANG Xi-qiang,et al.Significance on Cerebral Infarction’s Fatality Rate for the Retrospective Analysis of Hypertension under Serum Lipids Layer Management[J].Journal of Modern Laboratory Medicine,2017,32(06):97.[doi:10.3969/j.issn.1671-7414.2017.03.026]
[5]屈山脉,郭进京.脑梗死与脑出血患者相关生化指标水平差异及临床意义[J].现代检验医学杂志,2018,33(02):114.[doi:10.3969/j.issn.1671-7414.2018.02.001]
　QU Shan-mai,GUO Jin-jing.Clinical Significance and Difference of Some Biochemical Indexes in Patients with Cerebral Infarction and Cerebral Hemorrhage[J].Journal of Modern Laboratory Medicine,2018,33(06):114.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[6]韩　光.外周血血小板参数对评估急性脑梗死患者生活能力改善的临床价值[J].现代检验医学杂志,2020,35(02):119.[doi:10.3969 ／ j.issn.1671-7414.2020.02.033]
　HAN Guang.Clinical Value of Platelet Parameters in Evaluating the Improvement of LifeAbility in Patients with Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2020,35(06):119.[doi:10.3969 ／ j.issn.1671-7414.2020.02.033]
[7]欧鲤娴,孙清己,侯俊霞,等.脑梗死患者血清sdLDL，GSH-Px，Hcy及SDF-1水平与血管狭窄的相关性研究[J].现代检验医学杂志,2021,36(06):83.[doi:10.3969/j.issn.1671-7414.2021.06.017]
　OU Li-xian,Sun Qing-ji,HOU Jun-xia,et al.Study on the Correlation between Serum sdLDL, GSH-Px, Hcy and SDF-1 Levels and Vascular Stenosis in Patients with Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2021,36(06):83.[doi:10.3969/j.issn.1671-7414.2021.06.017]

备注/Memo

备注/Memo:
基金项目：邢台市重点研发计划自筹项目（编号：2020ZC319）。作者简介：王国玲（1985-），女，本科，中级职称，研究方向：脑血管病，E-mail:boboww@126.com。
更新日期/Last Update: 1900-01-01